For children who have milder forms of anxiety disorders, the clinician can use nonpharmaceutical treatment options to treat. Here are 7 approaches that can be used to mitigate the effects of a mild anxiety disorder.
Omalizumab outperforms oral immunotherapy in treating multi-food allergy
March 27th 2025A new clinical trial has found that omalizumab (Xolair; Genetech, Novartis) is more effective than oral immunotherapy (OIT) in treating multi-food allergy in individuals with severe allergic reactions to small amounts of common food allergens.